We examined the correlation between the transcriptomic expression of SPINK1 and a number of critical ICPs—PD-1, LAG-3, TIM-3, TIGIT, and CTLA-4—which are the likely signatures for the response to ICB in cancer immunotherapy (21, 38). The gene discussed is HAVCR2; the disease is cancer.